Overview of current policy for rare disease in China

2023-02-27T14:37:17+00:00News, White Paper|

For the first time after decades of negligence in this area, China published the First List of Rare Diseases (FLRDs). This was a key step in improving and standardising the regulatory system of rare disease management, orphan drug development, and review and approval.